DaVita Inc. $DVA Shares Acquired by American Century Companies Inc.

American Century Companies Inc. increased its position in shares of DaVita Inc. (NYSE:DVA) by 34.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,513 shares of the company’s stock after acquiring an additional 21,710 shares during the period. American Century Companies Inc. owned about 0.11% of DaVita worth $12,928,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC raised its position in DaVita by 2.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,551 shares of the company’s stock valued at $531,000 after purchasing an additional 69 shares in the last quarter. UMB Bank n.a. grew its stake in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $29,000 after buying an additional 76 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in DaVita by 8.9% during the 1st quarter. Exchange Traded Concepts LLC now owns 970 shares of the company’s stock worth $148,000 after acquiring an additional 79 shares during the period. Mather Group LLC. lifted its position in DaVita by 7.0% during the 1st quarter. Mather Group LLC. now owns 1,201 shares of the company’s stock worth $184,000 after acquiring an additional 79 shares during the period. Finally, National Pension Service lifted its position in DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company’s stock worth $30,000 after acquiring an additional 84 shares during the period. Institutional investors and hedge funds own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DVA shares. Barclays reduced their price target on DaVita from $169.00 to $160.00 and set an “equal weight” rating for the company in a report on Thursday, August 7th. Wall Street Zen raised DaVita from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Truist Financial set a $148.00 price target on DaVita in a research report on Friday, August 8th. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $164.00.

DaVita Trading Down 2.2%

NYSE:DVA opened at $137.3290 on Tuesday. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.34 and a current ratio of 1.39. DaVita Inc. has a one year low of $126.07 and a one year high of $179.60. The business’s 50-day simple moving average is $139.62 and its 200 day simple moving average is $143.45. The stock has a market cap of $9.82 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 1.01 and a beta of 1.09.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, topping the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion for the quarter, compared to analysts’ expectations of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company’s revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, sell-side analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total value of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company’s stock, valued at $3,905,700. This represents a 8.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.50% of the stock is owned by company insiders.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.